NASDAQ:PHAR
Pharming Group N.V.
- Stock
Last Close
0.91
26/04 16:35
Market Cap
788.51M
Beta: 0.95
Volume Today
580
Avg: 26.41K
PE Ratio
−37.26
PFCF: −31.36
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
asset turnover | 0.74 - | 0.54 26.42% | 0.48 12.22% | 0.48 0.96% | 0.53 9.75% | |
cash conversion cycle | 206.47 - | 161.95 21.56% | -216.32 233.57% | -203.26 6.04% | 653.18 421.34% | |
cash per share | 0.12 - | 0.32 174.81% | 0.30 7.53% | 0.32 6.63% | 0.32 2.01% | |
company equity multiplier | 2.18 - | 2.28 4.64% | 2.06 9.72% | 2.08 1.03% | 2.12 1.68% | |
days of inventory outstanding | 247.27 - | 305.26 23.45% | 493.38 61.63% | 879.68 78.30% | 821.73 6.59% | |
days of payables outstanding | 91.46 - | 194.34 112.49% | 767.29 294.81% | 1.13K 47.53% | 231.95 79.51% | |
days of sales outstanding | 50.66 - | 51.04 0.75% | 57.58 12.83% | 49.03 14.86% | 63.41 29.33% | |
dividend yield | ||||||
ebit per revenue | 0.36 - | 0.36 0.26% | 0.15 59.20% | 0.09 39.53% | -0.02 124.76% | |
ebt per ebit | 0.77 - | 0.58 24.55% | 0.79 36.86% | 0.82 3.86% | 2.23 171.28% | |
effective tax rate | 0.22 - | 0.14 35.90% | 0.31 113.13% | 0.09 71.45% | 0.12 39.12% | |
enterprise value multiple | 12.54 - | 8.27 34.03% | 9.95 20.25% | 21.72 118.38% | -311.87 1,535.94% | |
fixed asset turnover | 11.63 - | 10.53 9.45% | 5.73 45.59% | 5.25 8.33% | 7.33 39.55% | |
free cash flow per share | 0.08 - | 0.12 49.34% | 0.03 73.17% | 0.03 2.27% | -0.03 188.90% | |
gross profit margin | 0.87 - | 0.89 1.76% | 0.89 0.52% | 0.91 2.34% | 0.90 1.90% | |
interest coverage | 5.11 - | 12.83 151.02% | 4.71 63.32% | 3.40 27.69% | -0.90 126.54% | |
inventory turnover | 1.48 - | 1.20 19.00% | 0.74 38.13% | 0.41 43.91% | 0.44 7.05% | |
long term debt to capitalization | 0.04 - | 0.46 1,056.36% | 0.45 2.87% | 0.44 1.86% | 0.43 2.15% | |
net income per ebt | 0.78 - | 0.86 10.40% | 0.69 19.03% | 0.91 31.63% | 0.88 3.76% | |
net profit margin | 0.21 - | 0.18 16.92% | 0.08 54.78% | 0.07 17.33% | -0.04 164.66% | |
operating cash flow per share | 0.12 - | 0.14 20.12% | 0.06 60.65% | 0.04 37.51% | -0.03 174.89% | |
operating cycle | 297.93 - | 356.29 19.59% | 550.97 54.64% | 928.71 68.56% | 885.13 4.69% | |
operating profit margin | 0.36 - | 0.36 0.26% | 0.15 59.20% | 0.09 39.53% | -0.02 124.76% | |
payables turnover | 3.99 - | 1.88 52.94% | 0.48 74.67% | 0.32 32.22% | 1.57 388.02% | |
pretax profit margin | 0.28 - | 0.21 24.75% | 0.12 44.16% | 0.07 37.19% | -0.05 167.18% | |
price fair value | 8.20 - | 4.38 46.57% | 2.56 41.60% | 3.66 42.98% | 3.54 3.16% | |
receivables turnover | 7.21 - | 7.15 0.74% | 6.34 11.37% | 7.44 17.45% | 5.76 22.68% | |
return on assets | 0.16 - | 0.10 38.88% | 0.04 60.31% | 0.03 16.54% | -0.02 170.96% | |
return on capital employed | 0.48 - | 0.24 50.24% | 0.08 66.86% | 0.05 37.35% | -0.01 128.10% | |
return on equity | 0.35 - | 0.22 36.04% | 0.08 64.17% | 0.07 15.68% | -0.05 172.15% | |
total debt to capitalization | 0.33 - | 0.47 41.47% | 0.46 2.74% | 0.45 1.57% | 0.44 2.10% |
All numbers in USD (except ratios and percentages)